BOB体育

This study will evaluate safety and tolerability of ascending doses of nebulized KB407 in adults with cystic fibrosis.

Investigator

Jorge E Lascano

Ages

18 Years - N/A

Sexes

All

The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or IV). A pulmonary exacerbation is a worsening of鈥�

Investigator

Silvia Delgado

Ages

6 Years - N/A

Sexes

All

The purpose of this study is to evaluate the safety, and tolerability and efficacy of VX-522 in participants 18 years of age and older with cystic fibrosis and a cystic fibrosis transmembrane conductance regulator (CFTR) genotype not responsive to鈥�

Investigator

Cesar A Trillo-Alvarez

Ages

18 Years - 64 Years

Sexes

All

This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis.

Investigator

Cesar A Trillo-Alvarez

Ages

18 Years - N/A

Sexes

All